Contact Us
Drug Search Results
More Filters [+]

Etofenamate

Alternative Names: etofenamate, etofenamat
Latest Update: 2024-10-02
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: H1 Antagonist,COX Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Transdermal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Austria | Belgium | Bosnia | Brazil | Bulgaria | Chile | Colombia | Czech | Dominican Republic | Egypt | Estonia | Finland | Germany | Greece | Hong Kong | Hungary | Ireland | Italy | Latvia | Lebanon | Lithuania | Luxembourg | Malta | Mexico | Morocco | Netherlands | New Zealand | Peru | Poland | Portugal | Romania | Russia | Serbia | Slovakia | Slovenia | Spain | Sweden | Switzerland | Taiwan | Turkey | Uruguay | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Drossapharm AG
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Etofenamate

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Acute Pain|Acute Respiratory Distress Syndrome

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2021-003778-30

P3

Completed

Acute Respiratory Distress Syndrome|Acute Pain

2022-09-28

Recent News Events

Date

Type

Title

04/22/2024

PubMed

 First electrochemical investigation and determination of non-steroidal anti-inflammatory drug etofenamate using disposable pencil graphite electrode with voltammetric techniques.

09/26/2023

News Article

 The Future of Etofenamate Market - Size, Valuation, and Growth Prospects by 2031

09/12/2023

News Article

 Etofenamate Market Size, Current Insights and Demographic Trends 2023-2030

09/01/2023

PubMed

 The evaluation of the efficacy of etofenamate spray in postoperative cesarean pain: Randomized, double-blind, placebo-controlled trial.

08/01/2023

PubMed

 Placebo-controlled randomized double-blind comparison of the analgesic efficacy of lidocaine spray and etofenamate spray in pain control of rib fractures.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions